| 944836-22-0 |
(4S)-2-[2-[Bis[4-(trifluoromethyl)phenyl]phosphino]-5-(trifluoromethyl)phenyl]-4-tert-butyl-4,5-dihydrooxazole |
(4S)-2-[2-[双[4-(三氟甲基)苯基]膦]-5-(三氟甲基)苯基]-4-叔丁基-4,5-二氢恶唑 |
C28H23F9NOP |
591.45 |
| 541540-70-9 |
(R,R)-[2-(4'-i-Propyloxazolin-2'-yl)ferrocenyl]diphenylphosphine, min. 97% |
(R,R) - [2 - (4' - I - 苯基唑啉 -2 -基)二茂铁]二苯基膦 |
C28H22FeNOP |
475.31 |
| 212312-33-9 |
(3aR,8aS)-2-[2-(diphenylphosphino)phenyl]-3a,8a-dihydro-8H-Indeno[1,2-d]oxazole |
(3aR,8aS)-2-[2-(diphenylphosphino)phenyl]-3a,8a-dihydro-8H-Indeno[1,2-d]oxazole |
C28H22NOP |
419.45 |
| 1362386-02-4 |
Oxazole, 4-(1,1-dimethylethyl)-2-[2-(diphenylphosphino)phenyl]-4,5-dihydro-5,5-diphenyl-, (4S)- |
(S)-4-(叔丁基)-2-(2-(二苯基膦基)苯基)-5,5-二苯基-4,5-二氢恶唑 |
C37H34NOP |
539.65 |
| 1226898-27-6 |
(R)-4-tert-Butyl-2-[(SP)-2-(diphenylphosphino)ferrocenyl]-2-oxazoline |
(R)-4-TERT-BUTYL-2-[(SP)-2-(DIPHENYLPHOSPHINO)FERROCENYL]-2-OXAZOLINE |
C29H30FeNOP |
495.373361 |
| 167693-62-1 |
(S)-2-(2-(diphenylphosphino)phenyl)-4-isobutyl-4,5- dihydrooxazole |
167693-62-1 |
C25H26NOP |
387.45 |
| 163169-10-6 |
IP-FOXAP |
(S)-1-(二苯基磷酸)-2-[(S)-4-异丙基恶唑啉-2-基]二茂铁 |
C28H28FeNOP |
481.346781 |
| 163169-12-8 |
(2R)-1-[(4S)-4,5-dihydro-4-phenyl-2-oxazolyl]-2-(diphenylphosphino)-Ferrocene |
(2R)-1-[(4S)-4,5-DIHYDRO-4-PHENYL-2-OXAZOLYL]-2-(DIPHENYLPHOSPHINO)-FERROCENE |
C31H20FeNOP |
509.33 |
| 148461-16-9 |
(4S)-tert-Butyl-2-[2-(diphenylphosphino)phenyl]-4,5-dihydrooxazole |
(S)-4-叔丁基-2-[2-(二苯基膦基)苯基]-2-噁唑啉 |
C25H26NOP |
387.45 |
| 148461-14-7 |
(4S)-(-)-4,5-DIHYDRO-2-[2'-(DIPHENYLPHOSPHINO)PHENYL]-4-ISOPROPYLOXAZOLE |
二氢二苯磷苯基-4-异丙恶唑 |
C24H24NOP |
373.43 |